Heterogeneity of targeted lung lesion predicts platinum-based first-line therapy outcomes and overall survival for metastatic triple-negative breast cancer patients with lung metastasis: a “PET biopsy” method

Background: Platinum-based chemotherapy is widely used as first-line therapy for metastatic triple-negative breast cancer (mTNBC). Intratumor heterogeneity derived from fluorine-18 fluorodeoxyglucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT) is a potential predictor of tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Yizhao, Gu, Bingxin, Hu, Xichun, Zhang, Yingjian, Zhang, Jian, Wang, Zhonghua, Zhao, Yannan, Gong, Chengcheng, Li, Yi, Yang, Zhongyi, Wang, Biyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612961/
https://www.ncbi.nlm.nih.gov/pubmed/31308743
http://dx.doi.org/10.2147/CMAR.S204364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612961/
https://www.ncbi.nlm.nih.gov/pubmed/31308743
http://dx.doi.org/10.2147/CMAR.S204364

Ejemplares similares